PARPi Triggers the STING-dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness
Cancer Research - United States
doi 10.1158/0008-5472.can-18-1003
Full Text
Open PDFAbstract
Available in full text
Date
November 27, 2018
Authors
Publisher
American Association for Cancer Research (AACR)